Bayer obtains an exclusive worldwide license for MTA-cooperative PRMT5 inhibitor from Suzhou Puhe BioPharma for selective ...

As per Intent Market Research, the Methionine Market was valued at USD 6.0 billion in 2024-e and will surpass USD 9.1 billion by 2030; growing at a CAGR of 7.1% during 2024 - 2030.

The Vietnam Methionine Market was valued at USD 31.37 million in 2023 and is expected to experience steady growth, with a CAGR of 4.24% projected through 2029. Methionine, an essential amino acid, ...

Evonik is investing a low double-digit million euro sum to upgrade its European methionine Verbund in Antwerp and Wesseling, part of its global n ...

The following is a summary of “Ocular features of VEXAS syndrome: a systematic review and meta-analysis,” published in the ...

Evonik is continuing to optimise its global production setup for MetAMINO® (DL-methionine) with a technical upgrade of its ...

College of Life Science and Biotechnology, Heilongjiang Bayi Agricultural University, Daqing, Heilongjiang 163319, China Heilongjiang Provincial Key Laboratory of Environmental Microbiology and ...

Bayer, Puhe BioPharma ink global license agreement for clinical phase I PRMT5 inhibitor: Berlin, Germany Friday, March 28, 2025, 13:00 Hrs [IST] Bayer and Suzhou Puhe BioPharma Co ...

A short cut review was carried out to establish whether methionine was better than n-acetyl cysteine at reducing the severity of liver damage after paracetamol overdose. Thirty nine papers were found ...

The therapy, EPI-321, is intended to treat cases of facioscapulohumeral muscular dystrophy, a genetic neuromuscular disorder.